Crackdown on Illegal Ayurvedic Syrup Factory: An Inside Look

In Madhya Pradesh’s Indore district, officials sealed an illegal Ayurvedic syrup factory located in a residential area. The factory, overseen by Surendra Singh, was found lacking a quality-test lab and proper documentation. It was shut down for multiple regulatory infractions including hygiene and safety violations.

Authorities sealed an illegal Ayurvedic syrup factory in Indore district, Madhya Pradesh, on Thursday. The factory, located in a residential area in Dharampuri village, produced over 30 types of syrups.

The operation was led by Surendra Singh, who failed to provide essential documentation for the ingredients used in the syrup production. Furthermore, the facility lacked a laboratory for quality testing, raising significant safety and hygiene concerns.

The factory was shut down for violating pharmaceutical manufacturing regulations, and an investigation into the matter is ongoing, officials confirmed.

Related Posts

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre